CD40LG and COVID-19: With the use of 20 pre-COVID-19 sera, the specificity was 100% (83.16% to 100%) and 80% (56.34% to 94.27%) for EDI-IgG and IgM ELISA, respectively (P = 0.125) (Table 1).